CanniMed Therapeutics Inc.

CMED on TSXToday's ChangeVolume52 Week Range (Low/Hi)Market Cap
10.29CAN -0.11/-1.06%20,0007.32 / 13.35233.28 M
Powered by: Google Finance

Contact Information

CanniMed Therapeutics Inc.

Headquarters:
1 Plant Technology Road, Box 19A, RR#5
Saskatoon, Saskatchewan
Canada, S7K 3J8
Tel: 306-978-6848
Fax: 1‑844‑231‑8929
Email: Send a message
Website: Visit website
For more information...
Lead: Barry Mire

CanniMed Therapeutics Inc. (CMED) is a Canadian-based, international plant biopharmaceutical company and a leader in the Canadian medical cannabis industry. In addition, CMED has an active plant biotechnology research and product development program focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications.

CanniMed Ltd., a wholly-owned subsidiary of CMED, was the first producer to be licensed under the Marihuana for Medical Purposes Regulations (MMPR), the predecessor to the current Access to Cannabis for Medical Purposes Regulations (ACMPR).

Prairie Plant Systems Inc., a wholly-owned subsidiary of CMED, was the sole supplier to Health Canada under the former medical marijuana system for 13 years, and has been producing safe and consistent medical marijuana for thousands of Canadian patients, with no incident of diversion.

SubTerra LLC, is a wholly-owned subsidiary of CMED located in White Pine, Michigan, is a key strategic asset in the Company’s longer-term strategy to service a potential medical cannabis market in the United States.

Donald Ching - Chairman and Director
Brent Zettl - President, Chief Executive Officer and Director
John L. Knowles - Chief Financial Officer and Director
Gulwant Bajwa - Vice President, Business Development and Regulatory Affairs
Larry Holbrook - Chief Research Officer
 

Donald Ching - Chairman and Director
Brent Zettl - President, Chief Executive Officer and Director
John L. Knowles - Chief Financial Officer and Director
Doug Banzet - Director
Rob Duguid - Director
Marianne Greer - Director
Richard Hoyt - Director
Dwayne L. Lashyn - Director
Dr. Bruce F. Mackler - Director
Dr. Brandon J. Price - Director

 

Stock Information

CMED on TSX
10.29CAN
Today's Change
-0.11/-1.06%
Volume
20,000
52 Week Range (Low/Hi)
7.32 / 13.35
Market Cap
233.28 M

Company Overview

CanniMed Therapeutics Inc. (CMED) is a Canadian-based, international plant biopharmaceutical company and a leader in the Canadian medical cannabis industry. In addition, CMED has an active plant biotechnology research and product development program focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications.

CanniMed Ltd., a wholly-owned subsidiary of CMED, was the first producer to be licensed under the Marihuana for Medical Purposes Regulations (MMPR), the predecessor to the current Access to Cannabis for Medical Purposes Regulations (ACMPR).

Prairie Plant Systems Inc., a wholly-owned subsidiary of CMED, was the sole supplier to Health Canada under the former medical marijuana system for 13 years, and has been producing safe and consistent medical marijuana for thousands of Canadian patients, with no incident of diversion.

SubTerra LLC, is a wholly-owned subsidiary of CMED located in White Pine, Michigan, is a key strategic asset in the Company’s longer-term strategy to service a potential medical cannabis market in the United States.

Management

Donald Ching - Chairman and Director
Brent Zettl - President, Chief Executive Officer and Director
John L. Knowles - Chief Financial Officer and Director
Gulwant Bajwa - Vice President, Business Development and Regulatory Affairs
Larry Holbrook - Chief Research Officer
 

Board of Directors

Donald Ching - Chairman and Director
Brent Zettl - President, Chief Executive Officer and Director
John L. Knowles - Chief Financial Officer and Director
Doug Banzet - Director
Rob Duguid - Director
Marianne Greer - Director
Richard Hoyt - Director
Dwayne L. Lashyn - Director
Dr. Bruce F. Mackler - Director
Dr. Brandon J. Price - Director

 

Contact Information

Headquarters:
1 Plant Technology Road, Box 19A, RR#5
Saskatoon, Saskatchewan
S7K 3J8, Canada
Telephone: 306-978-6848
Fax: 1‑844‑231‑8929
Email: Send a message
Website: Visit website